Chemcon Speciality Chemicals Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹310(91.18%)
Premium (ELP)
Having completed its public offering, Chemcon Speciality Chemicals Limited's is now listed and trading on the NSE, BSE exchange as of Oct 01, 2020. The IPO raised cumulative capital of 93,52,940 Shares, including 48,52,940 Shares in primary capital infusion and ₹153.00 Cr in secondary market transactions.
The IPO was conducted with a price range of ₹338 to ₹340 and minimum investment requirement of 44 shares. subscription activity between Sep 21, 2020 and Sep 23, 2020 reflected market assessment of the offering's valuation and prospects.
The allotment process finalized on Sep 29, 2020 distributed equity ownership to successful bidders. The listing established a transparent market mechanism for share trading, price discovery, and investor participation in the company's future growth.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Chemcon Speciality Chemicals Ltd, incorporated in 1988, is engaged in the manufacturing of specialised chemicals such as HMDS and CMIC, along with oilfield chemicals including calcium bromide, sodium bromide, and zinc bromide, pharma intermediates, silanes, and contract manufacturing services. Pharmaceutical chemicals form the largest part of its revenue, with key customers comprising Hetero Labs, Laurus Labs, Aurobindo Pharma, Lantech Pharmaceuticals, and Macleods Pharma, while in the oilfield chemicals segment it caters to clients like Shree Radha Overseas, Universal Drilling Fluids, and Water Systems Speciality. In 2018, the company ranked as the eighth-largest HMDS manufacturer and the second-largest CMIC manufacturer globally, highlighting its strong market position. Chemcon serves both domestic and international markets, exporting to countries such as the USA, China, Japan, UAE, Serbia, Russia, Malaysia, and Azerbaijan, and operates its manufacturing facility at Manjusar near Vadodara, Gujarat, which includes five production plants, three owned warehouses, and two leased warehouses.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- World's largest producer of pharmaceutical chemicals.
- India's top manufacturer of oilfield chemicals.
- Serving customers across India and worldwide.
- Strong and steady financial growth.
- Specialized manufacturing plants for each product.
NA
- KamalKumar Rajendra Aggarwal
- Navdeep Naresh Goyal
- Shubharangana Goyal
Chemcon Speciality Chemicals Limited
Link Intime India Private Limited